0.9% Sodium Chloride Injection USP 50 mL Viaflex container Baxter Healthcare Corporation Deerfiel...
FDA Drug Recall #D-1190-2018 — Class II — September 6, 2018
Recall Summary
| Recall Number | D-1190-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | September 6, 2018 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Baxter Healthcare Corporation |
| Location | Deerfield, IL |
| Product Type | Drugs |
| Quantity | 5184 bags |
Product Description
0.9% Sodium Chloride Injection USP 50 mL Viaflex container Baxter Healthcare Corporation Deerfield, IL 60015 -- NDC 0338-0049-31
Reason for Recall
cGMP Deviation
Distribution Pattern
Nationwide.
Lot / Code Information
Lot: P380063 Exp. 12/2019
Other Recalls from Baxter Healthcare Corporation
| Recall # | Classification | Product | Date |
|---|---|---|---|
| D-0296-2026 | Class II | Sterile Water for Irrigation, 250 mL, Single-Do... | Dec 22, 2025 |
| D-0596-2025 | Class II | Acetaminophen Injection 1000 mg/100 mL (10 mg/m... | Aug 20, 2025 |
| D-0039-2025 | Class II | Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL)... | Oct 30, 2024 |
| D-0649-2024 | Class I | Heparin (Heparin Sodium in 0.9% Sodium Chloride... | Aug 1, 2024 |
| D-0587-2024 | Class II | Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dial... | Jun 17, 2024 |
Frequently Asked Questions
cGMP stands for Current Good Manufacturing Practice — the FDA's regulations governing drug manufacturing quality. A cGMP recall means the company failed to follow required manufacturing standards. This could involve inadequate testing, poor environmental controls, documentation failures, or process deviations. cGMP recalls do not always mean the product is directly harmful — in many cases, quality records are insufficient to confirm the product meets specifications. However, the FDA requires a recall because without proper documentation, product quality cannot be assured. These are often Class II or Class III recalls.
Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.
Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.
What Should You Do?
Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.